Important Safety Information for Lantus®
Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients
in Lantus®.
You must test your blood sugar levels while using insulin, such as Lantus®.
Do not make any changes to your dose or type of insulin without talking to your
healthcare provider. Any change of insulin should be made cautiously and only under
medical supervision.
Do NOT dilute or mix Lantus® with any other insulin or solution. It will
not work as intended and you may lose blood sugar control, which could be serious.
Lantus® must only be used if the solution is clear and colorless with no particles
visible. Do not share needles, insulin pens or syringes with others.
The most common side effect of insulin, including Lantus®, is low blood sugar
(hypoglycemia), which may be serious. Other possible side effects may include
injection site reactions, including changes in fat tissue at the injection site,
and allergic reactions, including itching and rash. In rare cases, some allergic
reactions may be life threatening.
Tell your doctor about other medicines and supplements you are taking because they
can change the way insulin works. Before starting Lantus®, tell your doctor
about all your medical conditions including if you have liver or kidney problems,
are pregnant or planning to become pregnant, or are breast-feeding or planning to
breast-feed.
Indications and Usage
Prescription Lantus® is a long-acting insulin used to treat adults with type
2 diabetes and adults and children (6 years and older) with type 1 diabetes for
the control of high blood sugar. It should be taken once a day at the same time
each day to lower blood glucose.
Do not use Lantus® to treat diabetic ketoacidosis.
Lantus® SoloSTAR® is a disposable prefilled insulin pen.
Click
here for additional important information for Lantus®.
Click here for information on drug anti-counterfeiting.
|
The health information contained herein is provided for general educational purposes
only. Your healthcare professional is the single best source of information regarding
your health. Please consult your healthcare professional if you have any questions
about your health or treatment.
|
*Based on TRX data from IMS Health, NPA™ Monthly database, time period
from May 2003 to September 2008.
†Needle not included with pen. Ultra-Fine is a trademark of Becton,
Dickinson and Company.
